about

Who We Are

Our Goal is to provide the gold-standard DNA for AAV manufacture

Touchlight AAV is a Joint Venture contract manufacturing organization formed by two leading biotechnology organizations within synthetic DNA and AAV manufacturing.

In 2020 Touchlight AAV launched its state-of-the-art facility located in San Sebastian, Spain. The facility is comprised of four suites and additional support labs, that are specifically designed for the manufacture of high quality dbDNA.

The company produces a synthetic DNA, dbDNA, as an alternative to plasmid DNA for the manufacture of adeno-associated virus (AAV).

We view dbDNA as a disruptive technology in the DNA market creating a new industry standard for transfection-based AAV production. Our synthetic process leads to high yield at small scales, shortening manufacturing timelines, facilitating quicker production of AAV and increasing safety by eliminating residual bacterial sequences of plasmid DNA in the AAV product.

Mission

To become the new industry standard DNA for AAV-based gene therapies.

Vision

To be a company with a strong technological base, which creates innovation and is a strategic partner in the development of gene therapies.

Values

We are an ethical company, results-oriented and focused on the value of people above any other consideration. Our primary aim is to contribute to healing those who are beyond the hope of traditional therapeutics.

Leadership/
Management Team

Photo
Alfredo Martínez
COO
Photo
Sarah Beaumont
Head of Business Development
Photo
Félix Bastida
Scientific Director
Photo
Lara Pascual
Financial Director
Photo
Jaime Vaquerizo
Director of Quality
Photo
María Dolores Gálvez
Supply Chain Director
Photo
Sergio Martín
Director of Engineering
Photo
Leticia Agundez
R&D Senior Manager
Photo
Sergio Cuesta
Manufacturing Manager
Photo
Lucía San Miguel
Quality Senior Manager